Clinical Trial Update: The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.

View source ↗

Summary

Clinical trial update evaluating injection site pain and adherence when switching from a low to high concentration AVT-02 (adalimumab) across multiple indicatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Hidradenitis Suppurativa
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• AVT-02 (adalimumab) (adalimumab)

Snippet

Sponsor: Jamp Pharma Corporation | Conditions: Crohn Disease, Ulcerative Colitis | Status: COMPLETED